Status:
UNKNOWN
The Effects of Enteral Whey Protein Supplement on Serum Albumin Level in Acute Critically Ill Neurological Patients
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Nutrition Disorders
Neurologic Disorder
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The incidence of malnutrition in patients with severe neurological diseases is approximately 37%, among which hypoproteinemia is a common manifestation. It has been confirmed that serum albumin level ...
Detailed Description
The purpose of the study is to compare standard enteral nutrition regimen with the enteral nutrition regimen supplemented with whey protein in severe neurological disease patients and to observe nutri...
Eligibility Criteria
Inclusion
- Clinical diagnosis of severe neurological Disease
- Serum albumin ≥30g/L
- Weight: 50\~90kg
- Nutrition risk screening 2002 (NRS2002) ≥3 points
- Acute gastrointestinal function injury (acute gastrointestinal injury, AGI) class 1\~2
- Expected enteral nutrition in tube feeding for at least 14 days
- Obtain the informed consent of the patient or its authorized client
Exclusion
- Pregnant and breast-feeding women
- Serious heart, lung and other important organ function injury
- Malignant tumor
- Hypothermia treatment
- BMI≥28
- Allergic to milk
- Receiving parenteral nutritional support therapy
- APACHE II ≥30
Key Trial Info
Start Date :
January 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT04361357
Start Date
January 5 2020
End Date
December 31 2022
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital
Beijing, China